ONE-YEAR RESULTS OF A FLEXIBLE REGIMEN WITH RANIBIZUMAB THERAPY IN MACULAR DEGENERATION-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ONE-YEAR RESULTS OF A FLEXIBLE REGIMEN WITH RANIBIZUMAB THERAPY IN MACULAR DEGENERATION

Published:2011-07 Issue:7 Volume:31 Page:1261-1267
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Arias Luis,Roman Isabel,Masuet-Aumatell Cristina,Rubio Marcos J,Caminal Josep M,Catala Jaume,Pujol Octavio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference17 articles.

1. Ranibizumab for neovascular age-related macular degeneration.;Rosenfeld;N Engl J Med,2006

2. Ranibizumab versus verteporfin for neovascular age-related macular degeneration.;Brown;N Engl J Med,2006

3. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.;Regillo;Am J Ophthalmol,2008

4. Guias de practica clinica de la SERV: Tratamiento de la degeneracion macular asociada a la edad (DMAE) exudativa.;Ruiz-Moreno;Arch Soc Esp Oftalmol,2009

5. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials.;Mitchell;Br J Ophthalmol,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression;Journal of Clinical Medicine;2022-01-10

2. Anti-Vascular Endothelial Growth Factor Dosing and Expected Acuity Outcome at 1 Year;Retina;2021-01-11

3. Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence;British Journal of Ophthalmology;2020-10-31

4. Visual benefit versus visual gain: what is the effect of baseline covariants in the treatment arm relative to the control arm? A pooled analysis of ANCHOR and MARINA;British Journal of Ophthalmology;2019-09-27

5. ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up;Graefe's Archive for Clinical and Experimental Ophthalmology;2017-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3